Breaking News Instant updates and real-time market news.

S

Sprint

$7.50

-0.08 (-1.06%)

, TMUS

T-Mobile

$61.52

0.02 (0.03%)

08:49
10/06/17
10/06
08:49
10/06/17
08:49

Sprint, T-Mobile deal likely to be announced with earnings, Bloomberg says

Sources tell Bloomberg that Sprint (S) and T-Mobile (TMUS) are ironing out the final details of a merger agreement that will likely be announced when the companies report earnings at the end of the month.

S

Sprint

$7.50

-0.08 (-1.06%)

TMUS

T-Mobile

$61.52

0.02 (0.03%)

  • 01

    Nov

S Sprint
$7.50

-0.08 (-1.06%)

09/28/17
RAJA
09/28/17
NO CHANGE
RAJA
DOJ appointment catalyst for CenturyLink, Level 3 deal, says Raymond James
Makan Delrahim was finally confirmed by the Senate yesterday as head of the Department of Justice Antitrust Division, Raymond James analyst Frank Louthan tells investors in a research note. He believes not having an antitrust head is at least partially to blame for the delay in mergers and acquisitions in the Technology & Communications space this year, including outstanding transactions like CenturyLink (CTL)/Level 3 Communications (LVLT) and AT&T (T)/Time Warner (TWX), as well as potential deals like Sprint (S)/T-Mobile U.S. (TMUS). The appointment of Delrahim is a catalyst for the approval of CenturyLink's acquisition of Level 3, where the Department of Justice has been the bottleneck, Louthan writes.
09/27/17
KEYB
09/27/17
UPGRADE
Target $170
KEYB
Overweight
SBA Communications upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Brandon Nispel upgraded SBA Communications (SBAC) to Overweight saying fears surrounding carrier consolidation has created a buying opportunity. Even with potential churn from customer consolidation, SBA's organic growth should accelerate into 2018 and 2019 with "carrier LTE-Advanced investments paving the way for 5G," Nispel tells investors in a research note. He also believes e combined T-Mobile (TMUS) and Sprint (S) would require more sites, not fewer. The analyst established a $170 price target for shares of SBA Communications.
09/26/17
JEFF
09/26/17
NO CHANGE
JEFF
Buy
T-Mobile shares could be worth over $90 with Sprint deal, says Jefferies
A merger between T-Mobile (TMUS) and Sprint (S) would make for a much stronger number three player in wireless and bring "massive" synergies, but regulatory approval, while not out of the question, remains uncertain, Jefferies analyst Mike McCormack tells investors in a research note. The analyst's initial pro forma analysis, which assumes an all-stock transaction at current market prices and synergies ramping to a $4.5B run rate in year three, suggests T-Mobile could be worth more than $90 per share in a deal scenario, or 43% above the current price. The stock closed yesterday down $1.17 to $62.89. McCormack also continues to see "significant value" in T-Mobile on a standalone basis. He has a Buy rating on the shares with an $80 price target.
09/25/17
CHLM
09/25/17
NO CHANGE
CHLM
Initial Apple iPhone 8 likely weaker than previous iPhones, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss says that initial Apple (AAPL) iPhone 8/8 Plus sales are likely weaker than previous generation iPhone launches as consumers wait for the iPhone X set to go on sale for preorders October 27th and live in store's November 3rd. The analyst believes lack of carrier sweetheart deals like with the iPhone 7 launch have led to lower consumer demand, with Sprint (S) being the only carrier currently offering a free 64GB iPhone 8 with eligible trade-in of select devices. Stoss also thinks consumers waiting for the iPhone X is a "strong" positive for STMicroelectronics (STM) as he believes it likely has about $6-$8 in content in the iPhone X versus $3-$4 in the iPhone 8/8 Plus.
TMUS T-Mobile
$61.52

0.02 (0.03%)

09/20/17
RHCO
09/20/17
NO CHANGE
RHCO
T-Mobile, Sprint merger unlikely to occur, says SunTrust
SunTrust analyst Greg Miller does not believe that Sprint (S) and T-Mobile (TMUS) will merge. He does not expect the Department of Justice to approve the deal, and he says that, given T--Mobile's ongoing positive momentum, the company probably does not feel any pressure to carry out a merger. The analyst believes that a cable company is more more likely to buy a smaller, independent wireless operator. He remains upbeat on cell tower stocks and says that yesterday's pullbacks in those names has created a buying opportunity. Miller keeps Buy ratings on tower companies American Tower (AMT), Crown Castle (CCI) and SBA (SBAC)

TODAY'S FREE FLY STORIES

LNKD

Acquired by MSFT

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Conference/Events
Detroit Economic Club to hold a breakfast meeting »

Brenda Meller, Owner and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MCS

Marcus

$26.10

1 (3.98%)

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Earnings
Marcus reports Q4 EPS $1.21, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    May

PHX

Panhandle Oil & Gas

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Initiation
Panhandle Oil & Gas initiated  »

Panhandle Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 11

    Mar

CRM

Salesforce

$114.48

0.13 (0.11%)

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

07:46
02/22/18
02/22
07:46
02/22/18
07:46
Conference/Events
FDA to co-host a workshop »

The FDA, American…

MLNX

Mellanox

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Recommendations
Mellanox analyst commentary  »

Mellanox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RDHL

RedHill Biopharma

$6.26

0.05 (0.81%)

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Earnings
RedHill Biopharma reports Q4 EPS (26c), consensus (60c) »

Reports Q4 revenue $2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

07:43
02/22/18
02/22
07:43
02/22/18
07:43
Conference/Events
JPMorgan to hold a conference »

Korea Conference will be…

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Conference/Events
Deutsche Bank to hold a conference »

Indonesia Corporate Days…

ROKU

Roku

$51.10

-0.08 (-0.16%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 21

    Mar

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

AKBA

Akebia

$14.31

0.69 (5.07%)

, CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

07:41
02/22/18
02/22
07:41
02/22/18
07:41
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

AKBA

Akebia

$14.31

0.69 (5.07%)

CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

RDUS

Radius Health

$37.71

-0.51 (-1.33%)

TYME

Tyme Technologies

$3.37

-0.06 (-1.75%)

HCA

HCA Healthcare

$100.35

-0.65 (-0.64%)

ARAY

Accuray

MDRX

Allscripts

$13.57

0.335 (2.53%)

ABEO

Abeona Therapeutics

$11.70

0.1 (0.86%)

SGEN

Seattle Genetics

$54.11

-0.05 (-0.09%)

INSY

Insys Therapeutics

$7.93

0.34 (4.48%)

SPPI

Spectrum

$20.51

0.21 (1.03%)

SPH

Suburban Propane

$24.10

-0.2 (-0.82%)

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

DEPO

Depomed

$7.46

0.07 (0.95%)

KTWO

K2M Group

$19.09

-0.01 (-0.05%)

INOV

Inovalon

$11.68

-1.025 (-8.07%)

IMMU

Immunomedics

$16.38

0.16 (0.99%)

OVID

Ovid Therapeutics

$6.83

-0.2 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 11

    Mar

  • 14

    Mar

  • 01

    May

  • 03

    May

  • 22

    Feb

HSC

Harsco

$16.75

0.45 (2.76%)

07:40
02/22/18
02/22
07:40
02/22/18
07:40
Earnings
Harsco reports Q4 EPS ex-items 20c, consensus 14c »

Reports Q4 revenue $455M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

WPC

W.P. Carey

$59.53

-0.73 (-1.21%)

07:40
02/22/18
02/22
07:40
02/22/18
07:40
Hot Stocks
W.P. Carey enters into 18-year triple net lease with Astellas Institute »

W. P. Carey has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

07:40
02/22/18
02/22
07:40
02/22/18
07:40
General news
Fed's Quarles anticipates further gradual tightening »

Fed's Quarles…

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:39
02/22/18
02/22
07:39
02/22/18
07:39
Earnings
Gibraltar Industries sees FY18 adjusted EPS $1.96-$2.08, consensus $1.81 »

Gibraltar is providing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$109.06

-1.92 (-1.73%)

07:39
02/22/18
02/22
07:39
02/22/18
07:39
Recommendations
Chevron analyst commentary  »

Chevron weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRC

Brady

$38.05

0.1 (0.26%)

07:38
02/22/18
02/22
07:38
02/22/18
07:38
Earnings
Brady reports Q2 EPS 8c, may not be compared to consensus 44c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:38
02/22/18
02/22
07:38
02/22/18
07:38
Earnings
Gibraltar Industries sees Q1 adjusted EPS 23c-28c, one est. 30c »

For Q1, the company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCN

Welltower

$53.99

-0.81 (-1.48%)

07:37
02/22/18
02/22
07:37
02/22/18
07:37
Earnings
Welltower sees 2018 normalized FFO $3.95-$4.05, consensus $4.20 »

Expects average blended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ARWR

Arrowhead

$5.54

-0.11 (-1.95%)

07:36
02/22/18
02/22
07:36
02/22/18
07:36
Hot Stocks
Arrowhead receives regulatory clearance to begin Phase 1 study of ARO-AAT »

Arrowhead Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AABA

Altaba

$75.11

0.52 (0.70%)

07:36
02/22/18
02/22
07:36
02/22/18
07:36
Recommendations
Altaba analyst commentary  »

Altaba price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

HCN

Welltower

$53.99

-0.81 (-1.48%)

07:36
02/22/18
02/22
07:36
02/22/18
07:36
Earnings
Welltower reports Q4 normalized FFO $1.02, consensus $1.04 »

Reports Q4 revenue $1.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROCK

Gibraltar Industries

$31.75

0.35 (1.11%)

07:35
02/22/18
02/22
07:35
02/22/18
07:35
Earnings
Gibraltar Industries reports Q4 adjusted EPS 41c, consensus 34c »

Reports Q4 revenue $258M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.